Speciality Medicines Ltd board authorizes four Key Managerial Personnel for determining materiality of events and making disclosures to stock exchanges.
Authorization occurred during board meeting held on April 28, 2026, from 3:30 PM to 4:00 PM.
Designated KMPs include Chairman & MD, Whole-time Director, and Company Secretary & Compliance Officer with specified contact details.